TW200621315A - Orally dissolving solid preparation - Google Patents

Orally dissolving solid preparation

Info

Publication number
TW200621315A
TW200621315A TW094137384A TW94137384A TW200621315A TW 200621315 A TW200621315 A TW 200621315A TW 094137384 A TW094137384 A TW 094137384A TW 94137384 A TW94137384 A TW 94137384A TW 200621315 A TW200621315 A TW 200621315A
Authority
TW
Taiwan
Prior art keywords
solid preparation
orally dissolving
dissolving solid
disintegrates
dissolves
Prior art date
Application number
TW094137384A
Other languages
Chinese (zh)
Inventor
Shigehiro Maetani
Yuichiro Kano
Hiroyuki Okazaki
Hiroyuki Kawashima
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of TW200621315A publication Critical patent/TW200621315A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

A solid preparation which can treat pain of throat and the like, and provide simultaneously a continuous disinfection of the oral cavity by a single preparation is provided. An orally dissolving solid preparation comprising a part containing an oral anti-inflammatory component which disintegrates or dissolves within 45 seconds to 2 minutes, and a part containing an oral disinfectant component which disintegrates or dissolves after 3 minutes, said disintegration time being measured by a disintegration test carried out according to disintegration test method defined in Japanese Pharmacopeia.
TW094137384A 2004-10-28 2005-10-25 Orally dissolving solid preparation TW200621315A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62262204P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
TW200621315A true TW200621315A (en) 2006-07-01

Family

ID=36227767

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094137384A TW200621315A (en) 2004-10-28 2005-10-25 Orally dissolving solid preparation

Country Status (5)

Country Link
JP (1) JP4812626B2 (en)
KR (1) KR20070069175A (en)
CN (1) CN101048149A (en)
TW (1) TW200621315A (en)
WO (1) WO2006046527A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
WO2008008801A2 (en) * 2006-07-11 2008-01-17 Mcneil Nutritionals, Llc Solid oral dosage vitamin and mineral compositions
CN101757629B (en) * 2010-02-05 2011-09-14 张福成 Medicine composition for treating acute and chronic aryngitis and preparation method thereof
CN102000005B (en) * 2010-11-27 2013-03-27 天津市顶硕科贸有限公司 Oral care solution
BR112013028968A2 (en) * 2011-05-12 2018-04-24 Smith & Nephew Orthopaedics Ag seaprose-containing wound debridement compositions and wound treatment methods using them
CN106727369B (en) * 2016-11-21 2020-01-21 珠海同源药业有限公司 Dequalinium chloride buccal tablet and preparation method thereof
CN107496911A (en) * 2017-10-20 2017-12-22 滕敏子 A kind of surgical site infections are used for anti-swelling, anti-infectious consolidant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62103012A (en) * 1985-10-23 1987-05-13 Eisai Co Ltd Multi-layered granule
JPS62246512A (en) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd Drug preparation having repeating action
JPH0717870A (en) * 1993-06-29 1995-01-20 Toshiko Yamamoto Troche
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
JP3730081B2 (en) * 2000-04-10 2005-12-21 大鵬薬品工業株式会社 Film troches

Also Published As

Publication number Publication date
JP4812626B2 (en) 2011-11-09
CN101048149A (en) 2007-10-03
JPWO2006046527A1 (en) 2008-05-22
WO2006046527A1 (en) 2006-05-04
KR20070069175A (en) 2007-07-02

Similar Documents

Publication Publication Date Title
TW200621315A (en) Orally dissolving solid preparation
ATE454132T1 (en) TABLET THAT MELTS QUICKLY IN THE ORAL CAVITY
MXPA06000852A (en) Orally dissolving films.
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
HUP0001089A2 (en) Dosage forms for ameliorating male erectile dysfunction
WO2006119300A3 (en) Method of using oxidative reductive potential water solution in dental applications
UA108360C2 (en) SOLID PHARMACEUTICAL COMPOSITION OF CORTICOSTEOIDE DECOMPOSING IN THE ORAL CAVITY
BR0210855A (en) Method of Manufacturing Extended Release Formulations
ECSP034922A (en) PIRROLOPIRIMIDINES
ATE374627T1 (en) MEDICAL DEVICES AND METHOD FOR THE PRODUCTION THEREOF
HK1118457A1 (en) Pharmaceutical forms with improved pharmacokinetic properties
ATE312635T1 (en) VALVE ARRANGEMENT
AU2002356786A1 (en) Orodispersible tablets containing fexofenadine
MXPA05011508A (en) Fast dissolving orally consumable films containing a sucralose as a sweetener.
DE60236149D1 (en) ARZNEIPASTILLE WITH SLOW RELEASE OF THE ACTIVE SUBSTANCE
MX2008011823A (en) Solid dosage form containing a taste masked active agent.
IL190194A0 (en) A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration
NO20031622L (en) Medical compositions that rapidly disintegrate in the oral cavity and process for the preparation of the same
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
WO2009078034A3 (en) Orally disintegrating tablets of ropinirole hydrochloride
MXPA04011835A (en) Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent.
MY144781A (en) Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
MXPA05008403A (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms.
MY136880A (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
RU2006126294A (en) METHOD FOR TREATING PATIENTS WITH CHRONIC FORMS OF PERIODONTITIS AND PERIODONTITIS IN THE STAGE OF EXCESSION